1. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients;Antiretroviral Therapy Cohort Collaboration (ART-CC);AIDS,2015
2. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation;Laprise;Clin. Infect. Dis.,2013
3. Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen;Gianotti;Int. J. Antimicrob. Agents,2018
4. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 08/06/2019.
5. Linee Guida Italiane Sull’utilizzo Della Terapia Antiretrovirale E La Gestione Diagnostico-clinica Delle Persone Con Infezione Da HIV-1;Ministero della Salute Italiano,2017